GenFleet Therapeutics

About:

GenFleet Therapeutics is a biotechnology developer and researcher of molecular pharmaceuticals targeting cancer treatments.

Website: http://www.genfleet.com/en

Top Investors: Shenzhen Capital Group, CSPC Pharmaceutical Group, Highlight Capital, CDH Investments, Ally Bridge Group

Description:

GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize the body's own immune system.

Total Funding Amount:

$169M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2017-01-01

Founders:

Lan Jiong, Qiang LU

Number of Employees:

101-250

Last Funding Date:

2021-12-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai